Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ
Onc206, Onc206: Dose 1, Onc206: Dose 2
Advanced Pheochromocytoma And Paraganglioma, Pcpg
Phase II
Recruiting
Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma
Dec 05, 2025
―
Carboplatin, Paclitaxel, Docetaxel, Zanidatamab, Trastuzumab, Pertuzumab
Her2-Positive Breast Cancer, Breast Cancer
Phase II
Recruiting
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Jul 28, 2025
―
Jzp441
Narcolepsy
Phase I
Recruiting
A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1
Apr 29, 2025
―
Zanidatamab
Esophageal Cancer, Pancreatic Cancer, Gastric Cancer, Non-small Cell Lung Cancer, Ovarian Cancer, Breast Cancer, Colorectal Cancer, Endometrial Cancer, Gastroesophageal Cancer, Urothelial Carcinoma, Salivary Gland Cancer, Her-2 Protein Overexpression
Phase II
Recruiting
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Nov 16, 2024
―
Gemcitabine, Zanidatamab, Capecitabine, Vinorelbine, Trastuzumab, Eribulin
Metastatic Her2-Positive Breast Cancer
Phase III
Recruiting
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
May 24, 2024
Pembrolizumab, Jzp898
Metastatic Solid Tumor, Advanced Solid Tumor
Phase I
Recruiting
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
Oct 19, 2023
―
Jzp258
Narcolepsy, Idiopathic Hypersomnia
Phase IV
Completed
A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy
May 16, 2023
―
Jzp258
Narcolepsy
Phase IV
Completed
A Switch Study From High-Sodium Oxybate to XYWAV to Evaluate Changes in Blood Pressure in Participants With Narcolepsy
May 12, 2023
―
Cannabidiol Oral Solution [Epidiolex]
Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
Phase IV
Active Not Recruiting
A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex
May 09, 2023
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Jazz Pharmaceuticals (JAZZ) have in its pipeline
JAZZ is currently developing the following drugs: Onc206, Onc206: Dose 1, Onc206: Dose 2, Carboplatin, Paclitaxel, Docetaxel, Zanidatamab, Trastuzumab, Pertuzumab, Jzp441. These drug candidates are in various stages of clinical development as the company works toward FDA approval.